Last updated on February 2015

A multinational, randomized, double-blind, placebo controlled trial to evaluate the effect of Ticagrelor 90mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus.


Brief description of study

A multinational, randomized, double-blind, placebo controlled trial to evaluate the effect of Ticagrelor 90mg twice daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients with Type 2 Diabetes Mellitus.

Detailed Study Description

Had a Blocked Artery? Worried about a heart attack or stroke? The THMIS study is researching a study drug to prevent heart attack and stroke in people with type 2 diabetes.

Clinical Study Identifier: TX140197

Contact Investigators or Research Sites near you

Start Over

Maggie Rosales

Arrowhead Health Centers
Glendale, AZ USA
  Connect »